Simcere Teams Up Again With Bristol-Myers For Co-Development In China
This article was originally published in PharmAsia News
Executive Summary
After signing a deal in deal in November 2010 for a MET-VEGFR-2 inhibitor, Simcere and BMS switch gears for a CETP inhibitor.